220 related articles for article (PubMed ID: 29753717)
1. TRIM38 regulates NF-κB activation through TAB2 degradation in osteoclast and osteoblast differentiation.
Kim K; Kim JH; Kim I; Seong S; Kim N
Bone; 2018 Aug; 113():17-28. PubMed ID: 29753717
[TBL] [Abstract][Full Text] [Related]
2. Rev-erbα Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway.
Kim K; Kim JH; Kim I; Seong S; Kim N
Mol Cells; 2020 Jan; 43(1):34-47. PubMed ID: 31896234
[TBL] [Abstract][Full Text] [Related]
3. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
4. Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation.
Lee J; Youn BU; Kim K; Kim JH; Lee DH; Seong S; Kim I; Han SH; Che X; Choi JY; Park YW; Kook H; Kim KK; Lim DS; Kim N
J Bone Miner Res; 2015 Sep; 30(9):1597-607. PubMed ID: 25761670
[TBL] [Abstract][Full Text] [Related]
5. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
Han SY; Lee KH; Kim YK
Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
[TBL] [Abstract][Full Text] [Related]
6. TRIM38 inhibits TNFα- and IL-1β-triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3.
Hu MM; Yang Q; Zhang J; Liu SM; Zhang Y; Lin H; Huang ZF; Wang YY; Zhang XD; Zhong B; Shu HB
Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1509-14. PubMed ID: 24434549
[TBL] [Abstract][Full Text] [Related]
7. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis.
Boyce BF; Li J; Yao Z; Xing L
Endocrinol Metab (Seoul); 2023 Oct; 38(5):504-521. PubMed ID: 37749800
[TBL] [Abstract][Full Text] [Related]
9. The IRF2BP2-KLF2 axis regulates osteoclast and osteoblast differentiation.
Kim I; Kim JH; Kim K; Seong S; Kim N
BMB Rep; 2019 Jul; 52(7):469-474. PubMed ID: 31186082
[TBL] [Abstract][Full Text] [Related]
10. TRAF family member-associated NF-κB activator (TANK) is a negative regulator of osteoclastogenesis and bone formation.
Maruyama K; Kawagoe T; Kondo T; Akira S; Takeuchi O
J Biol Chem; 2012 Aug; 287(34):29114-24. PubMed ID: 22773835
[TBL] [Abstract][Full Text] [Related]
11. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
12. [Establish mouse osteoblast -osteoclast cell co-culture system in a Transwell chamber].
Mo GY; Zhang SC; Li YX; Guo HZ; Guo DQ; Li DX; Tang YC; Mo L; Luo PJ; Ma YH
Zhongguo Gu Shang; 2018 Mar; 31(3):241-247. PubMed ID: 29600675
[TBL] [Abstract][Full Text] [Related]
13. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
14. Tusc2/Fus1 regulates osteoclast differentiation through NF-κB and NFATc1.
Kim I; Kim JH; Kim K; Seong S; Kim N
BMB Rep; 2017 Sep; 50(9):454-459. PubMed ID: 28391779
[TBL] [Abstract][Full Text] [Related]
15. Leonurus sibiricus L. ethanol extract promotes osteoblast differentiation and inhibits osteoclast formation.
Kim JH; Kim M; Jung HS; Sohn Y
Int J Mol Med; 2019 Sep; 44(3):913-926. PubMed ID: 31524244
[TBL] [Abstract][Full Text] [Related]
16. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
[TBL] [Abstract][Full Text] [Related]
17. The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 Sep; 30(3):708-12. PubMed ID: 22751682
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB.
Kim WS; Kim HJ; Lee ZH; Lee Y; Kim HH
Exp Cell Res; 2013 Feb; 319(4):436-46. PubMed ID: 23246654
[TBL] [Abstract][Full Text] [Related]
19. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.
Ikeda F; Nishimura R; Matsubara T; Tanaka S; Inoue J; Reddy SV; Hata K; Yamashita K; Hiraga T; Watanabe T; Kukita T; Yoshioka K; Rao A; Yoneda T
J Clin Invest; 2004 Aug; 114(4):475-84. PubMed ID: 15314684
[TBL] [Abstract][Full Text] [Related]
20. Regulatory mechanisms of osteoblast and osteoclast differentiation.
Katagiri T; Takahashi N
Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
